Literature DB >> 16186307

Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions.

Fernando Guerrero-Romero, Martha Rodríguez-Morán.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16186307     DOI： 10.2337/diacare.28.10.2588a

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  16 in total

1.  Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.

Authors:  Todd M Brown; Jenifer H Voeks; Vera Bittner; Monika M Safford
Journal:  Am Heart J       Date:  2010-03       Impact factor: 4.749

2.  Gastroesophageal reflux disease is inversely related with glycemic control in morbidly obese patients.

Authors:  Adriana Lauffer; Cassiano Mateus Forcelini; Liana Ortiz Ruas; Carlos Augusto Scussel Madalosso; Fernando Fornari
Journal:  Obes Surg       Date:  2011-07       Impact factor: 4.129

3.  The relation of metabolic syndrome according to five definitions to cardiovascular risk factors--a population-based study.

Authors:  Cheng-Chieh Lin; Chiu-Shong Liu; Chia-Ing Li; Wen-Yuan Lin; Ming-May Lai; Tsann Lin; Pei-Chia Chang; Yih-Dar Lee; Ching-Chu Chen; Chih-Hsueh Lin; Chuan-Wei Yang; Chih-Yi Hsiao; Walter Chen; Tsai-Chung Li
Journal:  BMC Public Health       Date:  2009-12-23       Impact factor: 3.295

4.  Metabolic syndrome: do clinical criteria identify similar individuals among overweight premenopausal women?

Authors:  Sofiya Alhassan; Alexandre Kiazand; Raymond R Balise; Abby C King; Gerald M Reaven; Christopher D Gardner
Journal:  Metabolism       Date:  2008-01       Impact factor: 8.694

5.  Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?

Authors:  Todd M Brown; Dhananjay Vaidya; William J Rogers; David D Waters; Barbara V Howard; Jean-Claude Tardif; Vera Bittner
Journal:  J Womens Health (Larchmt)       Date:  2008-06       Impact factor: 2.681

6.  Remission of metabolic syndrome: a study of 140 patients six months after Roux-en-Y gastric bypass.

Authors:  Marçal Rossi; Renato Barretto Fereira da Silva; Geraldo Chaves Alcântara; Paulo Fernando Regina; Felipe Martin Bianco Rossi; Ary Serpa Neto; Ethel Zimberg Chehter
Journal:  Obes Surg       Date:  2008-05       Impact factor: 4.129

7.  An examination of the prevalence of IDF- and ATPIII-defined metabolic syndrome in an Irish screening population.

Authors:  D F Waterhouse; A M McLaughlin; F Sheehan; D O'Shea
Journal:  Ir J Med Sci       Date:  2009-01-08       Impact factor: 1.568

8.  Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose.

Authors:  Wei-Yin Xiao; Ning Ning; Ming-Hong Tan; Xue-Shu Jiang; Liang Zhou; Ling Liu; Dong Yi; Ping Wei
Journal:  Hypertens Res       Date:  2016-01-14       Impact factor: 3.872

9.  Prevalence of metabolic syndrome using international diabetes federation, National Cholesterol Education Panel- Adult Treatment Panel III and Iranian criteria: results of Tabari cohort study.

Authors:  Adeleh Bahar; Zahra Kashi; Motahareh Kheradmand; Akbar Hedayatizadeh-Omran; Mahdi Moradinazar; Fatemeh Ramezani; Mahdi Afshari; Mahmood Moosazadeh
Journal:  J Diabetes Metab Disord       Date:  2020-01-17

10.  Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study.

Authors:  Ahmet Selcuk Can; Thomas P Bersot
Journal:  BMC Public Health       Date:  2007-12-19       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.